P. falciparum parasites (3D7 strain) were grown as asexual blood-stage cultures in RPMI media with AlbuMAX® (Gibco) and supplemented with GlutaMax® (Gibco), Gentamicin (Gibco) and HEPES (pH 7) with O+ human erythrocytes at 3% haematocrit. Cultures were maintained at 37 °C in a gaseous environment of 3% CO2, 1% O2 and 96% N2. Parasitemia and stages were monitored using Giemsa staining and microscopy. Parasite samples for long-read RNA-seq were harvested from a mixed-staged Pf3D7 culture. Parasite samples for short-read RNA-seq were harvested from synchronised Pf3D7 cultures at different time points around the intra-erythrocytic development cycle (0, 8, 16, 24, 32, 40 and 48 hours) with four replicates for each time point. RNA was extracted from parasites using Trizol as previously described [52].
Copyright and License information: The Author(s) ©2022 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this
article to respond.